Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 781 AL 795

Long-acting versus standard non-ergot dopamine agonists in Parkinson's disease: a meta-analysis of randomized controlled trials

Zhou CQ, Lou JH, Zhang YP, Zhong L, Chen YL, Lu FJ, Peng GG.

CNS Neurosci Ther. 2014 Apr;20(4):368-76. doi: 10.1111/cns.12239. Epub 2014 Mar 3.

Parkinson's disease with and without preceding essential tremor-similar phenotypes: a pilot study

Wurster I, Abaza A, Brockmann K, Liepelt-Scarfone I, Berg D.

J Neurol. 2014 May;261(5):884-8. doi: 10.1007/s00415-014-7285-z. Epub 2014 Mar 4.

Alcohol intake and risk of Parkinson's disease: a meta-analysis of observational studies

Zhang D, Jiang H, Xie J.

Mov Disord. 2014 May;29(6):819-22. doi: 10.1002/mds.25863. Epub 2014 Mar 3.

Orthostatic hypotension and cognitive impairment: a dangerous association?

Sambati L, Calandra-Buonaura G, Poda R, Guaraldi P, Cortelli P.

Neurol Sci. 2014 Jun;35(6):951-7. doi: 10.1007/s10072-014-1686-8. Epub 2014 Mar 4.

The FM/AM world is shaping the future of deep brain stimulation

Fasano A, Lozano AM.

Mov Disord. 2014 Feb;29(2):161-3. doi: 10.1002/mds.25834.

Deep brain stimulation surgery under general anaesthesia with microelectrode recording: the best of both worlds or a little bit of everything?

Warnke PC.

J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1063. doi: 10.1136/jnnp-2014-307745. Epub 2014 Mar 3.

Pharmacological chaperoning of nAChRs: a therapeutic target for Parkinson's disease

Srinivasan R, Henderson BJ, Lester HA, Richards CI.

Pharmacol Res. 2014 May;83:20-9. doi: 10.1016/j.phrs.2014.02.005. Epub 2014 Mar 1.

Parkinson's patient runs an ultra marathon: a case report

Daviet JC, Roy X, Quelven-Bertin I, Jallageas R, Mandigout S, Torny F, Monteil J.

Eur J Phys Rehabil Med. 2014 Aug;50(4):447-51. Epub 2014 Mar 5.

Genetic polymorphisms in VDR, ESR1 and ESR2 genes may contribute to susceptibility to Parkinson's disease: a meta-analysis

Gao Z, Fu HJ, Xue JJ, Wu ZX, Zhao LB.

Mol Biol Rep. 2014 Jul;41(7):4463-74. doi: 10.1007/s11033-014-3317-0. Epub 2014 Mar 5.

Tremor

Elias WJ, Shah BB.

JAMA. 2014 Mar 5;311(9):948-54. doi: 10.1001/jama.2014.1397.

Robot-assisted arm training in patients with Parkinson's disease: a pilot study

Picelli A, Tamburin S, Passuello M, Waldner A, Smania N.

J Neuroeng Rehabil. 2014 Mar 5;11:28. doi: 10.1186/1743-0003-11-28.

Latest concept of Lewy body disease

Kosaka K.

Psychiatry Clin Neurosci. 2014 Jun;68(6):391-4. doi: 10.1111/pcn.12179. Epub 2014 Apr 22.

Causes and consequences of degeneration of the dorsal motor nucleus of the vagus nerve in Parkinson's disease

Greene JG.

Antioxid Redox Signal. 2014 Aug 1;21(4):649-67. doi: 10.1089/ars.2014.5859. Epub 2014 Apr 28.

Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester

Hashim SA, VanItallie TB.

J Lipid Res. 2014 Sep;55(9):1818-26. doi: 10.1194/jlr.R046599. Epub 2014 Mar 5.

The role of L-DOPA in plants

Soares AR, Marchiosi R, Siqueira-Soares Rde C, Barbosa de Lima R, Dantas dos Santos W, Ferrarese-Filho O.

Plant Signal Behav. 2014;9(4):e28275. doi: 10.4161/psb.28275. Epub 2014 Mar 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias